Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

NCT00457015 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema (HAE)

Interventions

DRUG: ecallantide
DRUG: Phosphate Buffer Saline (PBS), pH 7.0

Sponsor

Shire